Doctor’s Thought Woman Had a Sinus Infection, But It Was Actually An Extremely Rare Cancer

Annika, a 28-year-old woman from California, shares a harrowing tale of battling a deadly sinus cancer that strikes fewer than one in a million individuals, ultimately leading to the removal of her right eye. A cancer so rare, there are less than 200 cases documented throughout medical literature.

Misdiagnosis: A Sinister Growth Mistaken for Routine Infection

Initially dismissed as a common sinus infection, Annika’s ordeal began when she woke up one morning in 2023 with discomfort in the inner corner of her right eye. Over the course of the day, the discomfort escalated into intense pain on the right side of her face, prompting her to seek medical help. Despite an initial diagnosis of a sinus infection, her condition worsened, with her face swelling around her right eye.

Read More: Doctors Thought Woman Had Cancer, But It Was Actually a Brain-Eating Amoeba

A Grim Discovery: The Unveiling of a Golf Ball-Sized Tumor

Following a second visit to the emergency room, medical professionals discovered a mass described as “about the size of a golf ball,” which had rapidly developed within a matter of weeks. This ominous growth led to a diagnosis of stage four sinonasal carcinoma SMARCB1, a rare and aggressive form of cancer that had already spread to her face, lungs, and lymph nodes.

So Rare, Only 200 Cases Ever Documented

Sinonasal carcinoma SMARCB1 is an exceedingly rare cancer, with fewer than 200 reported cases documented in medical literature. Originating in the nasal cavity, it constitutes just one percent of all head and neck cancers. This cancer is particularly insidious due to its rapid growth and tendency to metastasize early in its course, making it difficult to detect and treat effectively.

Read More: She Was Diagnosed With Stage 3 Cancer After Ignoring This ‘Embarrassing Symptom’

Understanding the Prognosis: Rare, Aggressive, and Poor

Despite ongoing research, much remains unknown about its prognosis, with the National Institutes of Health (NIH) indicating a survival rate of two to four years post-diagnosis, particularly grim for later-stage tumors. Factors contributing to its poor prognosis include its aggressive nature, propensity for early metastasis, and limited treatment options. Symptoms of sinonasal carcinoma SMARCB1 can vary widely but commonly include nasal obstructions, headaches, protrusion of the eyeball, and nosebleeds.

Treatment and Sacrifice: Chemotherapy, Surgery, and Loss

Annika embarked on a rigorous treatment regimen, commencing chemotherapy immediately after her diagnosis. However, her condition showed minimal improvement, leading to a surgical intervention in December 2023. The procedure, while necessary, resulted in the loss of her right eye, with surgeons also removing surrounding tissue to combat the invasive disease.

Hope Amidst Despair: An Experimental Path Forward

Despite the formidable odds stacked against her, Annika remains resilient, currently undergoing an experimental treatment plan that combines chemotherapy and immunotherapy in a bid to stall the progression of her illness. While statistics paint a bleak picture, Annika grapples with uncertainty regarding her prognosis, with no definitive timeline provided by medical professionals.

Facing the Unknown: Confronting Rare, Aggressive Cancer

Navigating the complexities of a rare, aggressive cancer, Annika confronts each day with courage and determination. While her journey is fraught with challenges and uncertainties, she remains steadfast in her resolve to defy the odds and embrace hope amidst adversity. As she shares her story on social media platforms like TikTok, Annika not only raises awareness about sinonasal carcinoma SMARCB1 but also offers a beacon of inspiration to others battling similar battles. ‘I know when you read about my cancer it’s “rare, aggressive, poor prognosis,” but no doctor has sat me down and been like “This is how long you have to live.”‘

Read More: Survey: Only 1% Of People Know The Tell-Tale Signs Of Some Of The Deadliest Cancers